Moderna, Inc. (MRNA) analyst actions
Rating and price-target actions on MRNA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MRNA overview →
2 measured MRNA analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus | Press release | +0.19% | +0.07% | |
| Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate | Press release | -0.63% | +0.09% |
Keep exploring
More MRNA: earnings → · SEC filings → · MRNA overview →